Nextron

Nextron Inc. is a home infusion therapy provider specializing in the administration of intravenous antibiotics, total parenteral nutrition (TPN), intravenous immunoglobulin (IVIG), biologic therapies such as Remicade, chemotherapy, and other parenteral medications delivered through multiple routes including intravenous, subcutaneous, intramuscular,... and intra-spinal methods. The company is committed to delivering comprehensive clinical care in patients' homes and other settings, including outpatient clinics, physician offices, and ambulatory infusion centers, thereby enabling patients to receive complex pharmaceutical treatments while maintaining comfort and privacy. Nextron's clinical teams consist of IV-certified registered nurses and registered pharmacists with extensive experience and proficiency in infusion therapy who develop individualized patient care plans and provide ongoing clinical monitoring throughout treatment. The company serves patients with a broad range of acute and chronic conditions, including infections, nutritional deficiencies, immunologic and neurologic disorders, oncology, pain management, and palliative care. Nextron maintains rigorous quality and safety standards, adhering to United States Pharmacopeia (USP) Chapter standards for compounding sterile medications and holding accreditation from the Accreditation Commission for Health Care (ACHC), an independent, not-for-profit organization that establishes performance-based standards for healthcare providers. The company's services are reimbursed through agreements with government payers including Medicare and Medicaid, managed care organizations (MCOs), and commercial insurance carriers, positioning Nextron as a trusted partner across multiple payer channels. By combining clinical expertise, regulatory compliance, and patient-centered care delivery, Nextron enables physicians to optimize treatment outcomes for patients requiring parenteral therapies while reducing the burden of hospital-based or facility-dependent care.Read More